Called 5-lipoxygenase.

Today the quantity of these amyloid plaques in the brain is used as a measurement of the severe nature of Alzheimer’s. ‘With ageing, the more 5-lipoxygenase you possess the more amyloid beta you are going to create. Related StoriesEight myths and truths about Alzheimer's diseaseDiscovery can offer clues to how some infections control expression of genetic materialExperimental drug candidate aimed at combating Alzheimer's disease offers anti-aging effects’It’s been known for a long time that the 5-lipoxygenase is an important proteins in the areas of the body, like the lung, but nobody really cared regarding its role in the brain,’ he said. ‘Predicated on some previously understand info, we questioned whether this enzyme was a principal or secondary player in the development of Alzheimer’s.Together with the Alzheimer’s program, we at Affiris are also attempting to develop and make available new medicines for the treatment of other major diseases such as atherosclerosis soon,’ explains scientist, founding CEO and person in Affiris GmbH, Dr. Walter Schmidt.

AORN conference: Integra LifeSciences launches 4 new products Integra LifeSciences introduced four new products today in the AORN conference in Denver, Colorado.